Author:
Bouazza Naïm,Cambonie Gilles,Flamant Cyril,Rideau Aline,Tauzin Manon,Patkai Juliana,Gascoin Géraldine,Lumia Mirka,Aikio Outi,Lui Gabrielle,Bournaud Léo Froelicher,Walsh-Papageorgiou Aisling,Tortigue Marine,Baruteau Alban-Elouen,Kallio Jaana,Hallman Mikko,Diallo Alpha,Levoyer Léa,Treluyer Jean-Marc,Roze Jean-Christophe
Funder
Innovative Medicines Initiatives 2 Join
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pediatrics, Perinatology and Child Health
Reference21 articles.
1. Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant. Pediatrics. 2020;146: e20201209.
2. Sivanandan S, Agarwal R. Pharmacological closure of patent ductus arteriosus: selecting the agent and route of administration. Paediatr Drugs. 2016;18:123–38.
3. Gournay V, Savagner C, Thiriez G, et al. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet Lond Engl. 2002;359:1486–8.
4. Benitz WE, Committee on Fetus and Newborn, American Academy of Pediatrics. Patent ductus arteriosus in preterm infants. Pediatrics. 2016. https://doi.org/10.1542/peds.2015-3730.
5. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010;2010:CD000174.